Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Corvus Pharmaceuticals Inc buy HC Wainwright

Start price
€13.70
20.01.26 / 50%
Target price
-
20.01.27
Performance (%)
17.81%
Price
€13.28
20.01.26
Summary
This prediction is currently active. The BUY prediction by HC_Wainwright currently has a performance of 17.81%. This prediction currently runs until 20.01.27. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this prediction
Performance without dividends (%)
Name 1w
Corvus Pharmaceuticals Inc 17.81%
iShares Core DAX® -3.141%
iShares Nasdaq 100 -3.518%
iShares Nikkei 225® -3.396%
iShares S&P 500 -2.943%

Comments by HC_Wainwright for this prediction

In the thread Corvus Pharmaceuticals Inc diskutieren

Corvus Pharmaceuticals (NASDAQ:CRVS) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Ratings data for CRVS provided by MarketBeat

Stopped prediction by HC_Wainwright for Corvus Pharmaceuticals Inc

buy
Corvus Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€3.00
26.03.25
€10.19
26.03.26
342.67%
20.01.26

buy
Corvus Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€5.03
14.01.25
€10.73
14.01.26
15.11%
15.01.26

buy
Corvus Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€5.15
02.01.25
€10.66
02.01.26
30.10%
03.01.26